Cesare Orlandi,David J. Clark,Imogene M. Dunn,Maria Carmen Valcarce Lopez,Matthew J. Kostura
申请号：
US15631203
公开号：
US20170326113A1
申请日:
2017.06.23
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention relates to methods of treatment using [3-(4-{2-butyl-1-[4-(4-chloro-phenoxy)-phenyl]-1H-imidazol-4-yl}-phenoxy)-propyl]-diethyl amine (“COMPOUND I”) or a pharmaceutically acceptable salt thereof. In various embodiments, the methods of treatment include treatment of mild-to-moderate dementia of Alzheimers type, diabetes, insomnia, and other indications. The present invention also relates to pharmaceutical compositions comprising COMPOUND I or a pharmaceutically acceptable salt thereof.
